Clover Health Investments Statistics Share Statistics Clover Health Investments has 512.14M
shares outstanding. The number of shares has increased by 2.3%
in one year.
Shares Outstanding 512.14M Shares Change (YoY) 2.3% Shares Change (QoQ) -0.39% Owned by Institutions (%) 21.3% Shares Floating 400.29M Failed to Deliver (FTD) Shares 83,502 FTD / Avg. Volume 0.92%
Short Selling Information The latest short interest is 50.28M, so 9.81% of the outstanding
shares have been sold short.
Short Interest 50.28M Short % of Shares Out 9.81% Short % of Float 12.3% Short Ratio (days to cover) 4.52
Valuation Ratios The PE ratio is -35.89 and the forward
PE ratio is -53.8.
Clover Health Investments's PEG ratio is
0.45.
PE Ratio -35.89 Forward PE -53.8 PS Ratio 1.13 Forward PS 0.6 PB Ratio 4.52 P/FCF Ratio 46.37 PEG Ratio 0.45
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Clover Health Investments.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.61,
with a Debt / Equity ratio of 0.
Current Ratio 1.61 Quick Ratio 1.61 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $2.41M Profits Per Employee $-75.45K Employee Count 570 Asset Turnover 2.36 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 9.56% in the
last 52 weeks. The beta is 1.97, so Clover Health Investments's
price volatility has been higher than the market average.
Beta 1.97 52-Week Price Change 9.56% 50-Day Moving Average 2.78 200-Day Moving Average 3.38 Relative Strength Index (RSI) 53.35 Average Volume (20 Days) 9,085,019
Income Statement In the last 12 months, Clover Health Investments had revenue of 1.37B
and earned -43.01M
in profits. Earnings per share was -0.09.
Revenue 1.37B Gross Profit 364.8M Operating Income -45.75M Net Income -43.01M EBITDA -44.94M EBIT -46.27M Earnings Per Share (EPS) -0.09
Full Income Statement Balance Sheet The company has 194.54M in cash and 0 in
debt, giving a net cash position of 194.54M.
Cash & Cash Equivalents 194.54M Total Debt n/a Net Cash n/a Retained Earnings -2.2B Total Assets 574.99M Working Capital 160.99M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 34.84M
and capital expenditures -1.56M, giving a free cash flow of 33.29M.
Operating Cash Flow 34.84M Capital Expenditures -1.56M Free Cash Flow 33.29M FCF Per Share 0.07
Full Cash Flow Statement Margins Gross margin is 26.61%, with operating and profit margins of -3.34% and -3.14%.
Gross Margin 26.61% Operating Margin -3.34% Pretax Margin -3.37% Profit Margin -3.14% EBITDA Margin -3.28% EBIT Margin -3.34% FCF Margin 2.43%
